1. Long Coding RNA XIST Contributes to Neuronal Apoptosis through the Downregulation of AKT Phosphorylation and Is Negatively Regulated by miR-494 in Rat Spinal Cord Injury
   Shixin Gu et al, 2017, IJMS CrossRef
2. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer
   BO LIU et al, 2016 CrossRef
3. Matrix metallopeptidase 9 targeted by hsa-miR-494 promotes silybin-inhibited osteosarcoma.
   Tianhao Sun et al, 2018, Mol Carcinog CrossRef
4. LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction
   Xing Chen et al, 2017, PLoS Comput Biol CrossRef
5. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients
   Jiajia Zhang et al, 2017, CBM CrossRef
6. miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2
   XIAOJUAN ZHAO et al, 2016 CrossRef
7. Analysis of different components in the peritumoral tissue microenvironment of colorectal cancer: A potential prospect in tumorigenesis
   Chao Huang et al, 2016 CrossRef
8. microRNA-494 is a potential prognostic marker and inhibits cellular proliferation, migration and invasion by targeting SIRT1 in epithelial ovarian cancer
   Aijun Yang et al, 2017 CrossRef
9. Proliferation-associated miRNAs-494, -205, -21 and -126 detected by in situ hybridization: expression and prognostic potential in breast carcinoma patients
   Natalia Gurvits et al, 2018, J Cancer Res Clin Oncol CrossRef
10. Heterogeneous nuclear ribonucleoprotein M promotes the progression of breast cancer by regulating the axin/β-catenin signaling pathway
    Wen-Hua Yang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
11. Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release
    Ramy El-Diwany et al, 2015, J. Virol. CrossRef
12. Long non-coding RNA XIST promotes the development of esophageal cancer by sponging miR-494 to regulate CDK6 expression.
    Zhenzhang Chen et al, 2019, Biomed Pharmacother CrossRef
13. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.
    Yu Zhou et al, 2018, Chin J Nat Med CrossRef
14. Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer
    Nijiro Nohata et al, 2017, J Hum Genet CrossRef
15. The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α.
    Constantino Martínez, 0 CrossRef
16. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494
    Xiaoni Han et al, 2016, Biochemical and Biophysical Research Communications CrossRef
17. MicroRNA-494 Inhibits the LRG1 Expression to Induce Proliferation and Migration of VECs in Rats following Myocardial Infarction
    Qiang Su et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
18. MicroRNAs Contribute to Breast Cancer Invasiveness.
    Ivana Fridrichova et al, 2019, Cells CrossRef
19. MicroRNAs in breast cancer: Roles, functions, and mechanism of actions
    Maryam Abolghasemi et al, 2019, J Cell Physiol CrossRef
20. Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells
    Marianne S. Andresen et al, 2020, Sci Rep CrossRef
21. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells
    Simona Salati et al, 2017, Oncotarget CrossRef
22. The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer
    Yin Peng et al, 2017, Oncotarget CrossRef
23. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration
    Thilde Terkelsen et al, 2020, Breast Cancer Res CrossRef
24. miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression.
    Lei Cheng et al, 0 CrossRef
25. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1
    Ying Yang et al, 2018, Int J Oncol CrossRef
26. miR‑494‑BAG‑1 axis is involved in cinobufacini‑induced cell proliferation and apoptosis in gastric cancer
    Zhili Shen et al, 2018, Mol Med Report CrossRef
27. CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma
    Rongjie Zhao et al, 2019, Aging CrossRef
28. Network characteristics of human RNA-RNA interactions and application in the discovery of breast cancer-associated RNAs
    Xingyong Zhu et al, 2020, Chemometrics and Intelligent Laboratory Systems CrossRef
29. QIMCMDA: MiRNA-Disease Association Prediction by q-Kernel Information and Matrix Completion
    Lin Wang et al, 2020, Front. Genet. CrossRef
30. Circular RNA circ_0081001 knockdown enhances methotrexate sensitivity in osteosarcoma cells by regulating miR-494-3p/TGM2 axis
    Wei Wei et al, 2021, J Orthop Surg Res CrossRef
31. Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas
    Zhanwei Wang et al, 2021, Human Immunology CrossRef
32. RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells
    Yuan Yang et al, 2018, oncol res CrossRef
33. Potential role of CXCR4 in trastuzumab resistance in breast cancer patients
    Ranim M. Kotb et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
34. Aberrant Regulation of CXCR4 in Cancer via Deviant MicroRNA-Targeted Interactions
    Alexei J. Stuckel et al, 2022, Epigenetics CrossRef
35. Chromosome 1p status in neuroblastoma correlates with higher expression levels of miRNAs targeting neuronal differentiation pathway
    Ozkan Bagci et al, 2023, In Vitro Cell.Dev.Biol.-Animal CrossRef
36. The Interrelationship Between FYN and miR-128/193a-5p/494 in Imatinib Resistance in Prostate Cancer
    Sercan Ergün et al, 2023, ACAMC CrossRef
37. miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy
    Iga Dziechciowska et al, 2023, CIMB CrossRef
38. Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain
    Silvia Sabattini et al, 2023, Vet Comparative Oncology CrossRef
39. Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR-9 pathway.
    Weidong Bing et al, 2016, J Cell Mol Med CrossRef